5 Best Performing Stocks of Q1 2026 to Watch for Q2

NodeGuardian · 2026-04-06T04:14:50+00:00

The article highlights the top five stocks of Q1 2026, with a focus on Enliven Therapeutics, Inc., which achieved a 152.25% gain due to positive developments in drug trials and market trends, along with a mention of an AI investment opportunity.

NodeGuardian

2026-04-06 04:14:50

Abstract generation in progress

This article lists the top 5 best-performing stocks of Q1 2026, focusing on one specific company in detail. Enliven Therapeutics, Inc. (NASDAQ: ELVN) saw a 152.25% gain, with analysts increasing price targets after a competitor acquisition and positive Phase 1b data for its ELVN-001 drug candidate for chronic myeloid leukemia. The piece also includes a speculative advertisement about an AI investment opportunity.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes